ESCCAL‐1, also called CASC9, was proved to facilitate the malignancy of CRC, EC, BC, lung cancer, glioma, ovarian cancer, and gastric cancer (GC).33, 34, 35, 36, 37, 38, 39, 40, 41. Here, CASC9 is linked to ovarian carcinoma.